Ізраїль - іврит - Ministry of Health

megapharm ltd - borneol; camphene; cineole; menthol; menthone; pinene; pinene - קפסולות - menthol 32 mg; menthone 6 mg; pinene 3.4 mg; borneol 5 mg; camphene 5 mg; cineole 2 mg; pinene 13.6 mg

Ізраїль - іврит - Ministry of Health

megapharm ltd - borneol; camphene; cineole; menthol; menthone; pinene; pinene - קפסולות - menthol 32 mg; menthone 6 mg; pinene 3.4 mg; borneol 5 mg; camphene 5 mg; cineole 2 mg; pinene 13.6 mg

Ізраїль - іврит - Ministry of Health

ס.מ חומרים טבעיים - לבישום הגוף

Ізраїль - іврит - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 24.242 mg - eletriptan

Ізраїль - іврит - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 48.485 mg - eletriptan

Ізраїль - іврит - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 96.97 mg - eletriptan

Ізраїль - іврит - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - ropeginterferon alfa-2b - תמיסה להזרקה - ropeginterferon alfa-2b 500 mcg/ml - ropeginterferon alfa-2b

Ізраїль - іврит - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - ropeginterferon alfa-2b - תמיסה להזרקה - ropeginterferon alfa-2b 1000 mcg/ml - ropeginterferon alfa-2b

Ізраїль - іврит - Ministry of Health

novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 30 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective.endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.

Ізраїль - іврит - Ministry of Health

novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 20 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.